TSOL18 vaccine and oxfendazole for control of Taenia solium cysticercosis in pigs: A field trial in endemic areas of Tanzania

被引:14
|
作者
Kabululu, Mwemezi L. [1 ]
Ngowi, Helena A. [2 ]
Mlangwa, James E. D. [2 ]
Mkupasi, Ernatus M. [2 ]
Braae, Uffe C. [3 ,4 ]
Colston, Angela [5 ]
Cordel, Claudia [6 ]
Poole, Elizabeth J. [7 ]
Stuke, Kristin [5 ]
Johansen, Maria V. [8 ]
机构
[1] Tanzania Livestock Res Inst TALIRI Uyole, Mbeya, Tanzania
[2] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Coll Vet Med & Biomed Sci, Morogoro, Tanzania
[3] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark
[4] Ross Univ, One Hlth Ctr Zoonoses & Trop Vet Med, Sch Vet Med, Basseterre, St Kitts & Nevi
[5] Global Alliance Livestock Vet Med GALVmed, Nairobi, Kenya
[6] Global Alliance Livestock Vet Med GALVmed, Bloemfontein, Free State, South Africa
[7] Stat Sustainable Dev Stats4SD, Reading, Berks, England
[8] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Pathobiol, Dept Vet & Anim Sci, Frederiksberg, Denmark
来源
PLOS NEGLECTED TROPICAL DISEASES | 2020年 / 14卷 / 10期
关键词
PORCINE CYSTICERCOSIS; MBEYA REGION; INTERVENTION; PREVALENCE;
D O I
10.1371/journal.pntd.0008785
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A field trial was conducted in Tanzania to determine the effectiveness of TSOL18 vaccine used concurrently with oxfendazole (OFZ), and of OFZ alone, onT.soliumcysticercosis determined by organ and half carcase dissection of slaughter age pigs. This study followed a quasi-experimental group design. Suitable trial sites were randomly allocated to either treatment group T1 (OFZ treatment alone [30mg/kg, Paranthic 10%]) or T2 (TSOL18 [1ml, Cysvax] plus OFZ). Three 4-monthly treatments were administered to eligible pigs. A random selection of pigs were necropsied at baseline and at endline, 2-3.5 months after the final treatment. Additionally, untreated pigs from T1 and T2 areas were necropsied at endline to provide contemporaneous comparisons with T1 and T2 pigs. Baseline prevalence of viableT.soliumcysticerci for T1 was 25.5% (Exact 95% CI: 13.9, 40.3; n = 12/47), and for T2 was 12.0% (CI: 6.4, 20.0; n = 12/100). At endline, prevalence was 2.8% for T1 (CI: 0.1, 14.5, n = 1/36) and 0% for T2 (CI: 0, 4.7, n = 0/77). Among untreated pigs, three had viable cysticerci, one from T1 area (12.5%, CI: 0.3, 52.7; n = 1/8) and two from T2 area (5.7%, CI: 0.7, 19.2, n = 2/35). Fisher's exact test showed significant changes in prevalence from baseline to endline in both groups (T1:p =0.005, T2:p =0.001). Firth's penalized Maximum Likelihood method suggested the changes were not significant relative to their controls (T1:p =0.245, T2:p =0.076). These findings showed a significant reduction in the prevalence of viable cysticerci from baseline to endline after both interventions. However, the changes could not be definitively attributed to the interventions due, in part, to small numbers of control pigs. Concurrent administration of the TSOL18 and OFZ cleared infection among assessed pigs whereas infection remained after treatment with OFZ only. Further studies including larger sample sizes would be required for more definitive conclusions. A One Health approach is recommended for rapid and sustainable impact. Author summary The pork tapewormT.soliumaffects the health and income of poor people in endemic areas. A pig vaccine-TSOL18, and a drug-oxfendazole (OFZ) present options for its control. In this study we assessed the effectiveness of the two tools against the parasite in pigs. We provided one group of pigs (T1) with a concurrent administration of TSOL18 and OFZ, and another group (T2) with OFZ only, in three rounds at 4 months intervals. We compared infection prevalence before and after the interventions by detection of cysticerci through carcase dissections. In addition, untreated pigs from the T1 and T2 areas were also sacrificed to serve as controls. We found a significant reduction in prevalence within the groups after the interventions. However, the reductions were not significant when compared with the reductions in the control groups, hence could not be definitively attributed to the interventions. Further, concurrent administration of TSOL18 and OFZ cleared infection among assessed pigs whereas OFZ alone did not clear the infection. Further studies would be required to make more definitive conclusions. We advocate for a One Health approach for a more rapid and sustainable impact.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 5 条
  • [1] Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon
    Assana, Emmanuel
    Kyngdon, Craig T.
    Gauci, Charles G.
    Geerts, Stanny
    Dorny, Pierre
    De Deken, Redgi
    Anderson, Garry A.
    Zoli, Andre P.
    Lightowlers, Marshall W.
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2010, 40 (05) : 515 - 519
  • [2] Anamnestic responses in pigs to the Taenia solium TSOL18 vaccine and implications for control strategies
    Lightowlers, Marshall W.
    Donadeu, Meritxell
    Elaiyaraja, M.
    Maithal, Kapil
    Kumar, K. Anand
    Gauci, Charles G.
    Firestone, Simon M.
    Sarasola, Patxi
    Rowan, Tim G.
    PARASITOLOGY, 2016, 143 (04) : 416 - 420
  • [3] Control trial of porcine cysticercosis in Uganda using a combination of the TSOL18 vaccination and oxfendazole
    Nsadha, Zachary
    Rutebarika, Chris
    Ayebazibwe, Chrisostom
    Aloys, Bukenya
    Mwanja, M.
    Poole, E. Jane
    Chesang, Elizabeth
    Colston, Angela
    Donadeu, Meritxell
    Lightowlers, Marshall W.
    INFECTIOUS DISEASES OF POVERTY, 2021, 10 (01)
  • [4] Control trial of porcine cysticercosis in Uganda using a combination of the TSOL18 vaccination and oxfendazole
    Zachary Nsadha
    Chris Rutebarika
    Chrisostom Ayebazibwe
    Bukenya Aloys
    M. Mwanja
    E. Jane Poole
    Elizabeth Chesang
    Angela Colston
    Meritxell Donadeu
    Marshall W. Lightowlers
    Infectious Diseases of Poverty, 10
  • [5] Trial Design for a Diagnostic Accuracy Study of a Point-of-Care Test for the Detection of Taenia solium Taeniosis and (Neuro)Cysticercosis in Community Settings of Highly Endemic, Resource-Poor Areas in Zambia: Challenges and Rationale
    Van Damme, Inge
    Trevisan, Chiara
    Mwape, Kabemba E.
    Schmidt, Veronika
    Magnussen, Pascal
    Zulu, Gideon
    Mubanga, Chishimba
    Stelzle, Dominik
    Bottieau, Emmanuel
    Abatih, Emmanuel
    Phiri, Isaac K.
    Johansen, Maria, V
    Chabala, Chishala
    Winkler, Andrea S.
    Dorny, Pierre
    Gabriel, Sarah
    DIAGNOSTICS, 2021, 11 (07)